Coloplast A/s Class B · OMXCOP:COLO_B
Coloplast A/s Class B — Q1 2005/06 Earnings Presentation
9 slides from Coloplast A/s Class B's earnings presentation, February 2006
Slide 1: Coloplast A/S Investor presentation Q1 2005/06
Coloplast A/S Investor presentation Q1 2005/06
Slide 2: Forward-looking statements; Changes in accounting principles (IFRS 2)
2 3 Forward-looking statements Changes in accounting principles (IFRS 2) • Share-based compensation is measured at fair value. The forward-looking statements contained in this presentation, including forecasts of sales and earnings performance, are not guarantees of future • For cashsettled, shareba
Slide 3: Expectations and long-term targets
6 7 Expectations and long-term targets Group Management Corporate Functions 2005/06 2005/06 Matrix Global Breast • Organic sales growth of around 10% in local currencies Ostomy Continence Wound & care care Skin care Operations care • Profit margin of just above 16% • CAPEX DKK 400mn Northern • Corpo
Slide 4: Continence care and wound care markets
10 11 Continence care Wound care - global market definition Wound type Acute Chronic European continence care market • Spinal cord injured, multiple sclerosis, 6½bn DKK spina bifida Dry 25% • Catheters, urine bags, urisheaths, wound € 0.9 billion € 1.5 billion healing bowel management 35% Product te
Slide 5: External factors - Demand outlook; Healthcare reforms
14 15 External factors - Demand outlook Healthcare reforms • UK Department of Health Consultation Demographics + • Suggest changes to existing system for reimbursement and Surgical and medical trends - /+ remuneration Reimbursement reforms - • Proposed reduction of reimbursement prices Health Care r
Slide 6: Global Operations - Hungary
18 19 Global Operations - Hungary Global Operations organisation Manufacturing New Products Supply Chain Quality & Business • Negligible restructuring costs • 700 headcounts in October 2005 & Distribution Introduction Improvement • 110 jobs affected • DKK 2bn sales value in 2006/07 • 25 vacant posit
Slide 7: Sterling Medical Services
22 23 Sterling Medical Services - Key facts Sterling Medical Services • US based company, founded in 1992 What Sterling brought to Coloplast: • Coloplast initial investment in 1998, • US net profit contribution full ownership in 2001, divested 2006 • Unique capability platform • 300 employees • Foot
Slide 8: Consolidated figures; Key financial ratios
25 26 Consolidated figures Key financial ratios As per 30 September 2005 mDKK 00/01 01/02 02/03 03/04 04/05 As per 30 September 2005 00/01 01/02 02/03 03/04 04/05 Net turnover 4,018 5,567 5,610 6,069 6,528 Profitability EBITDA1 878 1,157 1,195 1,295 1,353 Operating profit margin 15 16 16 16 15 EBITD
Slide 9: Analysts' estimates Q1 2005/06
29 30 Analysts’ estimates Q1 2005/06 Net Operating Profit PBT mDKK sales profit margin High 1,753 271 16.0% 251 Mean 1,702 256 15.1% 236 Low 1,586 241 14.1% 219 Coloplast actual 1,728 275 15.9% 236 Index to mean 102% 107% 106% 100%